Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John C Morris

Showing results (31-40 of 1,070) with videos related to

Pageof 107
Sort By:
Endocrine|July 1, 2019
The isolation of thyroxine (T4), the discovery of 3,5,3'-triiodothyronine (T3), and the identification of the deiodinases that generate T3 from T4: An historical reviewJohn C Morris, Valerie Anne Galton
Journal of Immunotoxicology|November 18, 2009
Transforming growth factor-beta: a target for cancer therapyRonan J Kelly, John C Morris
Mayo Clinic Proceedings|November 26, 2015
A Century of Hyperthyroidism at Mayo ClinicRobert C Smallridge, John C Morris
JAMA Neurology|November 30, 2020
Possible Consequences of the Approval of a Disease-Modifying Therapy for Alzheimer DiseaseErik S Musiek, John C Morris
JAMA Neurology|July 14, 2015
Factors Contributing to the Post-Lumbar Puncture Headache—ReplyRandall J Bateman, John C Morris
Archives of Neurology|July 13, 2005
Mild cognitive impairment as a clinical entity and treatment targetRonald C Petersen, John C Morris
Oncology (Williston Park, N.Y.)|February 4, 2010
Survivin(g) adult T-cell leukemia/lymphomaJohn E Janik, John C Morris
Alzheimer Disease and Associated Disorders|November 30, 2006
Workshop reports from the third Asia-pacific regional meeting of the international working group on harmonization of dementia drug guidelinesJohn C Morris, Jeffrey L Cummings
Expert Reviews in Molecular Medicine|October 1, 2009
Antibody-based therapy of leukaemiaJohn C Morris, Thomas A Waldmann
Journal of Clinical Neurology (Seoul, Korea)|July 23, 2011
Biomarkers predicting Alzheimer's disease in cognitively normal agingYong S Shim, John C Morris
Pageof 107

Showing results (31-40 of 1,070) with videos related to

Sort By:
Pageof 107
Endocrine|July 1, 2019
The isolation of thyroxine (T4), the discovery of 3,5,3'-triiodothyronine (T3), and the identification of the deiodinases that generate T3 from T4: An historical reviewJohn C Morris, Valerie Anne Galton
Journal of Immunotoxicology|November 18, 2009
Transforming growth factor-beta: a target for cancer therapyRonan J Kelly, John C Morris
Mayo Clinic Proceedings|November 26, 2015
A Century of Hyperthyroidism at Mayo ClinicRobert C Smallridge, John C Morris
JAMA Neurology|November 30, 2020
Possible Consequences of the Approval of a Disease-Modifying Therapy for Alzheimer DiseaseErik S Musiek, John C Morris
JAMA Neurology|July 14, 2015
Factors Contributing to the Post-Lumbar Puncture Headache—ReplyRandall J Bateman, John C Morris
Archives of Neurology|July 13, 2005
Mild cognitive impairment as a clinical entity and treatment targetRonald C Petersen, John C Morris
Oncology (Williston Park, N.Y.)|February 4, 2010
Survivin(g) adult T-cell leukemia/lymphomaJohn E Janik, John C Morris
Alzheimer Disease and Associated Disorders|November 30, 2006
Workshop reports from the third Asia-pacific regional meeting of the international working group on harmonization of dementia drug guidelinesJohn C Morris, Jeffrey L Cummings
Expert Reviews in Molecular Medicine|October 1, 2009
Antibody-based therapy of leukaemiaJohn C Morris, Thomas A Waldmann
Journal of Clinical Neurology (Seoul, Korea)|July 23, 2011
Biomarkers predicting Alzheimer's disease in cognitively normal agingYong S Shim, John C Morris
Pageof 107